Research Articles
CRISPR-Cas3: The Genome's Bulldozer Ushers in a New Era of Gene Editing
Explore CRISPR-Cas3, the genome's bulldozer that erases long DNA sections, offering new potential for curing viral infections and understanding non-coding DNA.
Green Revolution 2.0: Why Gene-Edited Plants Demand a New Approach to Risk Assessment
Exploring proportionate and scientifically sound risk assessment approaches for gene-edited plants, comparing global regulatory frameworks and technological innovations.
The Seed Wars: Should Gene-Edited Plants Be Patented?
Exploring the ethical, practical and regulatory arguments against patenting gene-edited plants and the implications for food security and agricultural innovation.
Genetic Engineers' Arsenal: How ZFNs, TALENs and CRISPR Are Revolutionizing Rat Research
Explore how ZFNs, TALENs and CRISPR gene-editing technologies are transforming rat research and biomedical science.
Designing Babies Through Gene Editing: From Science Fiction to Scientific Frontier
Exploring the science, ethics, and future of human genetic engineering through CRISPR technology and the controversial He Jiankui experiment.
The Gene Editing Revolution: From Lab Bench to Bedside in 2025
Comprehensive overview of current gene editing technologies, clinical progress, AI integration, and future directions in precision medicine.
Gene Editing and the Birth of the Hornless Bull
A breakthrough in gene editing technology produces hornless dairy cattle, offering a humane alternative to painful dehorning practices.
Ordo-Responsibility: The Ethical Compass for Germline Gene Editing
Exploring the ethical framework of ordo-responsibility for governing germline gene editing technologies like CRISPR-Cas9
Designing Humanity: The Revolutionary Science and Weighty Ethics of Gene-Edited Babies
Exploring the groundbreaking science, controversial applications, and profound ethical implications of gene editing in human reproduction.
Gilead's Gene-Editing Gambit: How Big Pharma is Betting on CRISPR 2.0
Explore Gilead's strategic partnerships in gene editing and targeted protein degradation technologies that are reshaping the future of medicine.